Predictive test for personalised anti-tumor treatment
Log in
Forgot your password?
Open account
fr en
0
0
View cart
  • Who are we ?
  • Technology
  • Diagnostic
  • Pharma/Biotech
  • CRO services
  • Publications
  • Partners
  • FAQ
  • Contact
Predictive test for personalised anti-tumor treatment
 

Exhibitions and events

List of headings :


Events & Conferences

Watch our webinars

Press Release: Oncomedics Awarded France 2030 Plan Grant

Limoges, March 14, 2025 – Oncomedics, a biotechnology company specializing in the personalization of cancer treatments and a member of the Oncomedics Group, has been named a laureate of the France 2030 Plan under the "Industrialization and Health Capacities 2030" call for projects. This second distinction, following its recognition under the France Relance program in 2021, will enable the large-scale industrialization of its innovative medical device: the Oncogramme®.

Partnership between Eurofins Biomnis and Oncomedics

Partnership between Eurofins Biomnis and Oncomedics

Oncomedics - Oncomedics Group - is pleased to announce its partnership with Eurofins Biomnis, European leader in specialized medical biology.

 


5 rue Gemini
87068 - France
Tel.: +33 5 55 33 85 25
Fax: +33 9 77 40 10 11
Email: info@oncomedics.com

Other information

How to order ?
Terms and conditions
Job vacancies
Who are we ?
Newsletter
Quality policies
Events
Legal notice

All trademarks or registered trademarks appearing on this website are the property of their respective owners
In
fr en